Amalgamated Bank’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,174
Closed -$21K 2559
2025
Q4
$21K Sell
2,174
-189
-8% -$1.61K ﹤0.01% 2093
2025
Q3
$10K Hold
2,363
﹤0.01% 2480
2025
Q2
$22K Hold
2,363
﹤0.01% 2080
2025
Q1
$23K Buy
2,363
+627
+36% +$7.76K ﹤0.01% 2015
2024
Q4
$21K Hold
1,736
﹤0.01% 2104
2024
Q3
$19K Hold
1,736
﹤0.01% 2156
2024
Q2
$16K Buy
1,736
+286
+20% +$1.99K ﹤0.01% 2220
2024
Q1
$12K Sell
1,450
-2,180
-60% -$17.9K ﹤0.01% 2364
2023
Q4
$31K Sell
3,630
-431
-11% -$5K ﹤0.01% 2449
2023
Q3
$69K Hold
4,061
﹤0.01% 2125
2023
Q2
$94K Sell
4,061
-547
-12% -$10.7K ﹤0.01% 2086
2023
Q1
$81K Sell
4,608
-638
-12% -$15.2K ﹤0.01% 2130
2022
Q4
$143K Hold
5,246
﹤0.01% 1982
2022
Q3
$91K Buy
5,246
+1,456
+38% +$27.8K ﹤0.01% 2188
2022
Q2
$66K Sell
3,790
-673
-15% -$11.1K ﹤0.01% 2347
2022
Q1
$76K Buy
+4,463
New +$84.2K ﹤0.01% 2302

Other funds holding REPL

Amalgamated Bank's REPL Position: Q1 2026 in Review

Amalgamated Bank sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 2,174 shares — an estimated $21K sold.

Amalgamated Bank first reported a position in REPL in Q1 2022 and held it in 16 quarters. The position peaked at $143K in Q4 2022. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Amalgamated Bank reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,174 Replimune Group shares in Q1 2026, an estimated $21K.
  • Amalgamated Bank first reported a position in Replimune Group in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Replimune Group position peaked at $143K in Q4 2022.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.